These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 7550355)

  • 1. Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy.
    Helbling-Leclerc A; Zhang X; Topaloglu H; Cruaud C; Tesson F; Weissenbach J; Tomé FM; Schwartz K; Fardeau M; Tryggvason K
    Nat Genet; 1995 Oct; 11(2):216-8. PubMed ID: 7550355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Readjusting the localization of merosin (laminin alpha 2-chain) deficient congenital muscular dystrophy locus on chromosome 6q2.
    Helbling-Leclerc A; Topaloglu H; Tomé FM; Sewry C; Gyapay G; Naom I; Muntoni F; Dubowitz V; Barois A; Estournet B
    C R Acad Sci III; 1995 Dec; 318(12):1245-52. PubMed ID: 8745640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of laminin chains in skin in merosin-deficient congenital muscular dystrophy.
    Sewry CA; D'Alessandro M; Wilson LA; Sorokin LM; Naom I; Bruno S; Ferlini A; Dubowitz V; Muntoni F
    Neuropediatrics; 1997 Aug; 28(4):217-22. PubMed ID: 9309712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Muscular dystrophies due to alterations at extracellular space level: congenital muscular dystrophy caused by merosin deficiency].
    Smeyers P
    Rev Neurol; 1999 Jan 16-31; 28(2):141-9. PubMed ID: 10101782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel mutations in LAMA2 gene responsible for a severe phenotype of congenital muscular dystrophy in two Tunisian families.
    Louhichi N; Richard P; Triki CH; Meziou M; Ayadi H; Guicheney P; Fakhfakh F
    Arch Inst Pasteur Tunis; 2006; 83(1-4):19-23. PubMed ID: 19388593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal diagnosis in laminin alpha2 chain (merosin)-deficient congenital muscular dystrophy: a collective experience of five international centers.
    Vainzof M; Richard P; Herrmann R; Jimenez-Mallebrera C; Talim B; Yamamoto LU; Ledeuil C; Mein R; Abbs S; Brockington M; Romero NB; Zatz M; Topaloglu H; Voit T; Sewry C; Muntoni F; Guicheney P; Tomé FM
    Neuromuscul Disord; 2005 Oct; 15(9-10):588-94. PubMed ID: 16084089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substitution of a conserved cysteine-996 in a cysteine-rich motif of the laminin alpha2-chain in congenital muscular dystrophy with partial deficiency of the protein.
    Nissinen M; Helbling-Leclerc A; Zhang X; Evangelista T; Topaloglu H; Cruaud C; Weissenbach J; Fardeau M; Tomé FM; Schwartz K; Tryggvason K; Guicheney P
    Am J Hum Genet; 1996 Jun; 58(6):1177-84. PubMed ID: 8651294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Merosin-deficient congenital muscular dystrophy, autosomal recessive (MDC1A, MIM#156225, LAMA2 gene coding for alpha2 chain of laminin).
    Allamand V; Guicheney P
    Eur J Hum Genet; 2002 Feb; 10(2):91-4. PubMed ID: 11938437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Merosin-deficient congenital muscular dystrophy type 1A.
    Buteică E; Roşulescu E; Burada F; Stănoiu B; Zăvăleanu M
    Rom J Morphol Embryol; 2008; 49(2):229-33. PubMed ID: 18516331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refinement of the laminin alpha2 chain locus to human chromosome 6q2 in severe and mild merosin deficient congenital muscular dystrophy.
    Naom IS; D'Alessandro M; Topaloglu H; Sewry C; Ferlini A; Helbling-Leclerc A; Guicheney P; Weissenbach J; Schwartz K; Bushby K; Philpot J; Dubowitz V; Muntoni F
    J Med Genet; 1997 Feb; 34(2):99-104. PubMed ID: 9039983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of merosin-negative congenital muscular dystrophy to chromosome 6q2 by homozygosity mapping.
    Hillaire D; Leclerc A; Fauré S; Topaloglu H; Chiannilkulchaï N; Guicheney P; Grinas L; Legos P; Philpot J; Evangelista T
    Hum Mol Genet; 1994 Sep; 3(9):1657-61. PubMed ID: 7833925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Congenital muscular dystrophy with merosin deficiency: clinical, histopathological, immunocytochemical and genetic analysis].
    Fardeau M; Tomé FM; Helbling-Leclerc A; Evangelista T; Ottolini A; Chevallay M; Barois A; Estournet B; Harpey JP; Fauré S; Guicheney P; Hillaire D
    Rev Neurol (Paris); 1996 Jan; 152(1):11-9. PubMed ID: 8729391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Merosin-positive congenital muscular dystrophy: a large inbred family.
    Mahjneh I; Bushby K; Anderson L; Muntoni F; Tolvanen-Mahjneh H; Bashir R; Pizzi A; Brockington M; Marconi G
    Neuropediatrics; 1999 Feb; 30(1):22-8. PubMed ID: 10222457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in LAMA2 and CAPN3 genes associated with genetic and phenotypic heterogeneities within a single consanguineous family involving both congenital and progressive muscular dystrophies.
    Hadj Salem I; Kamoun F; Louhichi N; Rouis S; Mziou M; Fendri-Kriaa N; Makni-Ayadi F; Triki C; Fakhfakh F
    Biosci Rep; 2011 Apr; 31(2):125-35. PubMed ID: 20477750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe congenital muscular dystrophy in a Mexican family with a new nonsense mutation (R2578X) in the laminin alpha-2 gene.
    Coral-Vazquez RM; Rosas-Vargas H; Meza-Espinosa P; Mendoza I; Huicochea JC; Ramon G; Salamanca F
    J Hum Genet; 2003; 48(2):91-5. PubMed ID: 12601554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preserved merosin M-chain (or laminin-alpha 2) expression in skeletal muscle distinguishes Walker-Warburg syndrome from Fukuyama muscular dystrophy and merosin-deficient congenital muscular dystrophy.
    Voit T; Sewry CA; Meyer K; Hermann R; Straub V; Muntoni F; Kahn T; Unsöld R; Helliwell TR; Appleton R
    Neuropediatrics; 1995 Jun; 26(3):148-55. PubMed ID: 7477753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetically confirmed patients with merosin-deficient congenital muscular dystrophy in China.
    Yuan J; Takashima H; Higuchi I; Arimura K; Li N; Zhao Z; Shen H; Hu J
    Neuropediatrics; 2008 Oct; 39(5):264-7. PubMed ID: 19294599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression profiling of muscles from Fukuyama-type congenital muscular dystrophy and laminin-alpha 2 deficient congenital muscular dystrophy; is congenital muscular dystrophy a primary fibrotic disease?
    Taniguchi M; Kurahashi H; Noguchi S; Sese J; Okinaga T; Tsukahara T; Guicheney P; Ozono K; Nishino I; Morishita S; Toda T
    Biochem Biophys Res Commun; 2006 Apr; 342(2):489-502. PubMed ID: 16487936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan.
    Brockington M; Blake DJ; Prandini P; Brown SC; Torelli S; Benson MA; Ponting CP; Estournet B; Romero NB; Mercuri E; Voit T; Sewry CA; Guicheney P; Muntoni F
    Am J Hum Genet; 2001 Dec; 69(6):1198-209. PubMed ID: 11592034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Non-Fukuyama type congenital muscular dystrophy--merosin deficient and positive forms].
    Nonaka I
    Nihon Rinsho; 1997 Dec; 55(12):3176-80. PubMed ID: 9436431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.